Back to Search
Start Over
Role of TP53 mutations in predicting response to TKI treatment in EGFR-mutated NSCLC patients
- Source :
- Journal of Clinical Oncology. 34:9052-9052
- Publication Year :
- 2016
- Publisher :
- American Society of Clinical Oncology (ASCO), 2016.
-
Abstract
- 9052Background: Patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations are usually responsive to tyrosine kinase inhibitors (TKIs). However, ab...
- Subjects :
- 0301 basic medicine
Cancer Research
integumentary system
biology
business.industry
Tp53 mutation
respiratory tract diseases
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
Cancer research
biology.protein
Medicine
Non small cell
Epidermal growth factor receptor
business
Tyrosine kinase
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........cb05858651cc87ac503aab53c5c8a99c
- Full Text :
- https://doi.org/10.1200/jco.2016.34.15_suppl.9052